Skip to content
Hugin
Hugin / Topic

prescription-drugs

Every record this desk has filed under prescription-drugs, newest first, each with the number of sources it can still show you.

7 recordsSeptember 30, 2026 – November 9, 2026All topics
  1. News1 receipt2 min

    CMS finalizes Medicare drug negotiation regulations for prices beginning in 2029

    The Centers for Medicare & Medicaid Services has finalized regulations for Medicare's drug price negotiation program and Part D coverage. The rule takes legal effect December 5, 2026, but generally applies to negotiated prices in 2029 and later and to Part D coverage beginning January 1, 2029. Earlier negotiation years remain governed by existing guidance; this rule does not itself announce a newly negotiated drug price.

    Also filed undermedicaredrug-pricescmsfederal-rule

  2. News4 receipts2 min

    Labor's final PBM rule requires fee disclosure and audit access for covered large self-insured health plans

    A Labor Department final rule scheduled for Federal Register publication November 2 requires covered pharmacy-benefit service providers to disclose compensation to fiduciaries of large self-insured ERISA health plans. It also provides audit access and machine-readable compensation information on request. The requirements apply to plan years beginning on or after July 1, 2027; the rule does not promise lower individual prescription prices.

    Also filed underhealth-planspharmacy-benefit-managersfee-disclosureerisafederal-register

  3. News3 receipts2 min

    FDA final guidance explains when prescription-drug apps belong in a medicine's official labeling

    FDA released final guidance on October 20 about software disseminated by or on behalf of prescription-drug sponsors, followed by an October 21 Federal Register notice. It addresses app content, prescribing information and submissions for FDA review. The guidance is nonbinding, and the notice permits comments at any time rather than setting a new closing date.

    Also filed underhealthdigital-healthlabelingfdafederal-register

  4. News3 receipts5 min

    CMS proposes a Medicare rule that would eliminate some generic-drug copays, require Medicare Advantage provider-directory accuracy, and limit PBM pay, starting in 2028

    The Centers for Medicare & Medicaid Services has proposed a rule, scheduled to be published in the Federal Register on October 20, 2026, to carry out three sections of the Consolidated Appropriations Act, 2026. It would zero out the generic-drug copay for about 6 million low-income enrollees, make Medicare Advantage plans verify their provider directories and charge only the lower cost sharing when an enrollee relied on a wrong listing, and limit pharmacy benefit manager pay to flat service fees, mostly from 2028. Comments are due at 5 p.m. Eastern Standard Time on December 15, 2026.

    Also filed undermedicaremedicare-advantagepharmacy-benefit-managersfederal-register

  5. News1 receipt2 min

    Medicare's annual open enrollment begins October 15, with plan changes due by December 7

    Medicare's annual October 15–December 7 window opens today for changes to Medicare Advantage and prescription drug coverage. Medicare says coverage starts January 1 when the plan receives an enrollment request by December 7. This is a plan-choice window, with separate considerations for drug coverage and Medigap when returning to Original Medicare.

    Also filed undermedicareenrollmenthealth-coverageconsumer-information

  6. Commentary9 receipts6 min

    Medicare's open enrollment starts October 15, and the numbers that matter this fall are not the averages

    CMS projects the average Medicare Advantage premium will fall to $12 a month in 2027, and says about eight in ten enrollees can keep their plan at the same or a lower premium. Those are averages. What decides one person's year is the plan's change letter, the drug benefit's new limits, and two blanks an agent who sells for more than one company must fill in before talking about benefits. Open enrollment runs October 15 to December 7.

    Also filed undermedicarehealth-insuranceopen-enrollmentconsumer-protection

  7. News2 receipts3 min

    CMS's final GLOBE rule, scheduled to publish October 2, adds rebates on certain Part B drugs tied to other countries' prices and can cut some patients' coinsurance from April 2027.

    CMS's final rule creating the GLOBE Model is on public inspection and scheduled to publish October 2; it takes effect November 30, 2026. Makers of certain Medicare Part B drugs must take part and may owe rebates measured against other countries' prices. From April 1, 2027, people in Original Medicare in randomly chosen ZIP codes can pay less coinsurance on covered drugs. CMS says patients do not have to enroll or take any action.

    Also filed undermedicarepart-bcmsfederal-registerdrug-pricing

A record appears here because it carries prescription-drugs in its own tags. If a record you expected is missing, it was filed under a different subject — the full list is on the topics index.